To define a dose-response relationship after intrinsically labeled milk protein ingestion on myofibrillar and mitochondrial muscle protein synthesis after a single bout of endurance exercise.
ID
Source
Brief title
Condition
- Protein and amino acid metabolism disorders NEC
- Muscle disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Myofibrillar, and mitochondrial protein bound [13C6] phenylalanine and [13C6]
leucine enrichments.
Secondary outcome
Plasma glucose, insulin, leucine, phenylalanine, tyrosine, plasma
[13C6]phenylalanine, plasma [13C6] leucine, plasma D5-phenylalanine and plasma
(3,5-D2)-tyrosine enrichments.
Background summary
Dietary protein intake after exercise is necessary to maximally stimulate
muscle protein synthesis rates [1]. Previous studies have shown that the
ingestion of 20 grams of both egg and whey protein is sufficient to maximize
both mixed and myofibrillar muscle protein synthesis after resistance type
exercise [2, 3]. In addition, it has been observed that 20 grams of protein
intake is sufficient to maximize myofibrillar muscle protein synthesis, but not
mitochondrial muscle protein synthesis, after endurance exercise [4]. It is
reasonable to suggest that mitochondrial muscle protein synthesis is most
important for endurance athletes, as it will improve the oxidative capacity of
the skeletal muscle in this athletic population. It remains to be elucidated
whether higher doses (>20 grams) of protein ingestion are necessary to enhance
mitochondrial muscle protein synthesis rates after endurance exercise. In
addition, the effects of different doses of milk protein, as source of dietary
protein, have never been tested on myofibrillar and mitochondrial muscle
protein synthesis after endurance exercise. We aim to fill these gaps in our
understanding.
Study objective
To define a dose-response relationship after intrinsically labeled milk protein
ingestion on myofibrillar and mitochondrial muscle protein synthesis after a
single bout of endurance exercise.
Study design
Parallel design, randomized, placebo controlled, double blind.
Intervention
Subjects will perform endurance exercise and consume a combination of
carbohydrate (45 gr) and different doses of intrinsically labeled milk protein
(0, 15, 30, 45 gr). In addition, continuous intravenous tracer infusions will
be applied, with plasma and muscle samples collected.
Study burden and risks
The risks involved in participating in this experiment are minimal. Insertion
of the catheters in a vein is comparable to a normal blood draw and the only
risk is a small local hematoma. This is also true for muscle biopsies. Muscle
biopsies will be taken through a small (5 mm) incision, following local
anaesthetic of the skin and muscle fascia, and will heal completely. Muscle
biopsies will only be obtained by an experienced physician. The labeled,
non-radioactive amino acids tracers that will be infused intravenously are
produced according to GMP standards and are safe for human use. There is no
risk associated with the DEXA scan. The radiation dose emitted during a DEXA
scan is 0.001 mSv. This is a very low exposure compared to the total background
radiation in the Netherlands, which is ~2.5 mSv/year. For comparison, the
radiation dose during a flight higher than 10 km is 0.005 mSV*h-1.
Universiteitssingel 50 G2.224
Maastricht 6200 MD
NL
Universiteitssingel 50 G2.224
Maastricht 6200 MD
NL
Listed location countries
Age
Inclusion criteria
- Males
- Aged between 18-35 years inclusive
- Bodyweight between 60-95 kg inclusive
- Healthy, moderately trained
- BMI < 30 kg/m2
- Having given informed consent
Exclusion criteria
- Having any identified metabolic or intestinal disorders
- Use of tobacco products
- Non-steroidal anti-inflammatory drugs (NSAID) in the 4 days prior to the experimental trial
- Allergies to milk proteins (whey or casein)
- Arthritic conditions
- A history of neuromuscular problems
- Previous participation in amino acid tracer studies
- Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
- Diabetes
- Training more than 6 days per week
- VO2max < 35 ml/kg/min or > 70 ml/kg/min
- Lactose Intolerance
- Phenylketonuria
- Blood donation within 2 months of study initiation
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL52519.068.15 |
OMON | NL-OMON24647 |